Indomethacin inhibits thymic involution in mice with streptozotocin-induced diabetes

Comparative Medicine

Volumn 57, Issue 5, 2007, Pages 476-481

  Mic, Ani A ^a   Mic, Felix A ^b,d   Tatu, Calin A ^a   Ionac, Mihai ^c   Ordodi, Valentin L ^a   Paunescu, Virgil ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Performa Diagnostics SRL   (Romania)

^c Pius Branzeu Center for Laparoscopic Surgery and Microsurgery   (Romania)

^d Timisoara County Hospital ^*  (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; INDOMETACIN; STREPTOZOCIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIABETES MELLITUS; DRUG INHIBITION; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INVOLUTION; MOUSE; NONHUMAN; WEIGHT REDUCTION; ANIMAL; BLOOD; CELL CULTURE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; MOUSE STRAIN; ORGAN SIZE; PATHOLOGY; SIGNAL TRANSDUCTION; THYMUS;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CELLS, CULTURED; CORTICOSTERONE; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; FLOW CYTOMETRY; INDOMETHACIN; MICE; MICE, INBRED STRAINS; ORGAN SIZE; SIGNAL TRANSDUCTION; THYMUS GLAND;

EID: 38449093548     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Basu S, Larsson A, Vessby J, Vessby B, Berne C. 2005. Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation. Diabetes Care 28:1371-1375.
2. Briede J, Daija D, Stivrina M, Duburs G. 1999. Effect of cerebrocrast on the lymphocyte blast transformation activity in normal and streptozotocin-induced diabetic rats. Cell Biochem Funct 17:89-96.
3. Chatamra K, Daniel PM, Kendall MD, Lam DK. 1985. Atrophy of the thymus in rats rendered diabetic by streptozotocin. Horm Metab Res 17:630-632.
4. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. 2001. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257-3265.
5. Fehsel K, Kroncke KD, Kolb H, Kolb-Bachofen V. 1994. In situ nick translation detects focal apoptosis in thymuses of glucocorticoid- and lipopolysaccharide-treated mice. J Histochem Cytochem 42:613-619.
6. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415.
7. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNFα- and obesity-induced insulin resistance. Science 271:665-668.
8. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91.
9. Hughes JH, Easom RA, Wolf BA, Turk J, McDaniel ML. 1989. Interleukin 1-induced prostaglandin E2 accumulation by isolated pancreatic islets. Diabetes 38:1251-1257.
10. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. 1967. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 126:201-205.
11. Kaya Dagistanli F, Susleyici Duman B, Ozturk M. 2005. Protective effects of a calcium channel blocker on apoptosis in thymus of neonatal STZ-diabetic rats. Acta Histochem 107:207-214.
12. Lee JY, Sohn KH, Rhee SH, Hwang D. 2001. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase 2 mediated through toll-like receptor 4. J Biol Chem 276:16683-16689.
13. Like AA, Rossini AA. 1976. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 425:415-417.
14. Litherland SA, Xie XT, Hutson AD, Wasserfall C, Whittaker DS, She JX. Hofig A, Dennis MA, Fuller K, Cook R, Schatz D, Moldawer LL, Clare-Salzler MJ. 1999. Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest 104:515-523.
15. Magarinos AM, McEwen BS. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. 2000. Proc Natl Acad Sci U S A 97:11056-11061.
16. Mic FA, Molnar P, Kresztes T, Szegezdi E, Fesus L. 1999. Clearance of apoptotic thymocytes is decreased by inhibitors of eicosanoid synthesis. Cell Death Differ 6:593-595.
17. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. 2000. Glucose challenge stimulates reactive oxygen species (ROS) generation by leukocytes. J Clin Endocrinol Metab 85:2970-2973.
18. Paik SG, Fleischer N, Shin SI. 1980. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc Natl Acad Sci U S A 77:6129-6133.
19. Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF Jr. 1977. Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci U S A 74:2485-2489.
20. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, Feldman EL. 2002. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16:1738-1748.
21. Sandler S, Andersson A, Hellerstrom C. 1987. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121:1424- 1431.
22. Schein P, Kahn R, Gorden P, Wells S, Devita VT. 1973. Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature. Arch Intern Med 132:555-561.
23. Scribner KA, Walker CD, Cascio CS, Dallman MF. 1991. Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 129:99-108.
24. Tabata T, Okuno Y, Fujii S, Kimura S, Kinoshita Y. 1984. Maturational impairment of thymic lymphocytes in streptozotocin-induced diabetes in rats. Cell Immunol 89:250-258.
25. Tabatabaie T, Waldon AM, Jacob JM, Floyd RA, Kotake Y. 2000. COX2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin- treated mice. Biochem Biophys Res Commun 273:699-704.
26. Wellhausen SR. 1986. Definition of streptozocin toxicity for primary lymphoidal tissues. Diabetes 35:1404-1411.